Biblio | Neurology

Found 54 results

Filters: Keyword is Multiple Sclerosis [Clear All Filters]

2023

Williams MJ, Okai AF, Cross AH, Monson NL, Vartanian T, Thrower BW, Reder AT, English JB, Wu GF, Bernitsas E et al.. 2023. Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.. Mult Scler Relat Disord. 76:104794.

Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen H-C, Carruthers R et al.. 2023. Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.. Proc Natl Acad Sci U S A. 120(3):e2207291120.

Shetty SV, Mazzucco MR, Winokur P, Haigh SV, Rumah KRashid, Fischetti VA, Vartanian T, Linden JR. 2023. Epsilon Toxin Binds to and Kills Primary Human Lymphocytes.. Toxins (Basel). 15(7)

Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al.. 2023. Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)

2022

Cho J, Nguyen TD, Huang W, Sweeney EM, Luo X, Kovanlikaya I, Zhang S, Gillen KM, Spincemaille P, Gupta A et al.. 2022. Brain oxygen extraction fraction mapping in patients with multiple sclerosis.. J Cereb Blood Flow Metab. 42(2):338-348.

Longbrake EE, Hua LH, Mowry EM, Gauthier SA, Alvarez E, Cross AH, Pei J, Priest J, Raposo C, Hafler DA et al.. 2022. The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.. Mult Scler Relat Disord. 68:104143.

Li J, Huang W, Luo X, Wen Y, Cho J, Kovanlikaya I, Gauthier SA, Nguyen TD, Spincemaille P, Wang Y. 2022. The central vein sign in multiple sclerosis lesions: Susceptibility relaxation optimization from a routine MRI multiecho gradient echo sequence.. J Neuroimaging. 32(1):48-56.

Marcille M, Rúa SHurtado, Tyshkov C, Jaywant A, Comunale J, Kaunzner UW, Nealon N, Perumal JS, Zexter L, Zinger N et al.. 2022. Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis.. Sci Rep. 12(1):4411.

Perumal J, Balabanov R, Su R, Chang R, Balcer LJ, Galetta SL, Avila RL, Rutledge D, Fox RJ. 2022. Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.. CNS Drugs. 36(9):977-993.

Rúa SMHurtado, Kaunzner UW, Pandya S, Sweeney E, Tozlu C, Kuceyeski A, Nguyen TD, Gauthier SA. 2022. Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients.. Eur J Neurol. 29(1):237-246.

Dimov AV, Gillen KM, Nguyen TD, Kang J, Sharma R, Pitt D, Gauthier SA, Wang Y. 2022. Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation.. Tomography. 8(3):1544-1551.

Zhang H, Nguyen TD, Zhang J, Marcille M, Spincemaille P, Wang Y, Gauthier SA, Sweeney EM. 2022. QSMRim-Net: Imbalance-aware learning for identification of chronic active multiple sclerosis lesions on quantitative susceptibility maps.. Neuroimage Clin. 34:102979.

Huang W, Sweeney EM, Kaunzner UW, Wang Y, Gauthier SA, Nguyen TD. 2022. Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination.. J Neuroimaging. 32(4):667-675.

Kim J, Nguyen TD, Zhang J, Gauthier SA, Marcille M, Zhang H, Cho J, Spincemaille P, Wang Y. 2022. Subsecond accurate myelin water fraction reconstruction from FAST-T data with 3D UNET.. Magn Reson Med. 87(6):2979-2988.

Dimov AV, Nguyen TD, Gillen KM, Marcille M, Spincemaille P, Pitt D, Gauthier SA, Wang Y. 2022. Susceptibility source separation from gradient echo data using magnitude decay modeling.. J Neuroimaging. 32(5):852-859.

Pitt D, Lo CHung, Gauthier SA, Hickman RA, Longbrake E, Airas LM, Mao-Draayer Y, Riley C, De Jager PLawrence, Wesley S et al.. 2022. Toward Precision Phenotyping of Multiple Sclerosis.. Neurol Neuroimmunol Neuroinflamm. 9(6)

2021

Zhang H, Zhang J, Li C, Sweeney EM, Spincemaille P, Nguyen TD, Gauthier SA, Wang Y, Marcille M. 2021. ALL-Net: Anatomical information lesion-wise loss function integrated into neural network for multiple sclerosis lesion segmentation.. Neuroimage Clin. 32:102854.

Grigg JB, Shanmugavadivu A, Regen T, Parkhurst CN, Ahmed A, Joseph AM, Mazzucco M, Gronke K, Diefenbach A, Eberl G et al.. 2021. Antigen-presenting innate lymphoid cells orchestrate neuroinflammation.. Nature. 600(7890):707-712.

Ontaneda D, Raza PC, Mahajan KR, Arnold DL, Dwyer MG, Gauthier SA, Greve DN, Harrison DM, Henry RG, Li DKB et al.. 2021. Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement.. Brain. 144(7):1974-1984.

Tozlu C, Jamison K, Gu Z, Gauthier SA, Kuceyeski A. 2021. Estimated connectivity networks outperform observed connectivity networks when classifying people with multiple sclerosis into disability groups.. Neuroimage Clin. 32:102827.

Sweeney EM, Nguyen TD, Kuceyeski A, Ryan SM, Zhang S, Zexter L, Wang Y, Gauthier SA. 2021. Estimation of Multiple Sclerosis lesion age on magnetic resonance imaging.. Neuroimage. 225:117451.

Perumal J, Balabanov R, Su R, Chang R, Balcer L, Galetta S, Campagnolo DI, Avila R, Lee L, Rutledge D et al.. 2021. Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.. Adv Ther. 38(7):3724-3742.

Gillen KM, Mubarak M, Park C, Ponath G, Zhang S, Dimov A, Levine-Ritterman M, Toro S, Huang W, Amici S et al.. 2021. QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions.. Ann Clin Transl Neurol. 8(4):877-886.

Tozlu C, Jamison K, Nguyen T, Zinger N, Kaunzner U, Pandya S, Wang Y, Gauthier S, Kuceyeski A. 2021. Structural disconnectivity from paramagnetic rim lesions is related to disability in multiple sclerosis.. Brain Behav. 11(10):e2353.

2020

Zhang J, Liu Z, Zhang S, Zhang H, Spincemaille P, Nguyen TD, Sabuncu MR, Wang Y. 2020. Fidelity imposed network edit (FINE) for solving ill-posed image reconstruction.. Neuroimage. 211:116579.